Attentional Bias Modification Training for Quitting Smoking
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a computer-based method to help young adults quit using e-cigarettes. It aims to reduce their attention to e-cigarette cues and support them in staying smoke-free. Participants will receive either the real training, known as Computerized Attentional Bias Modification Training, or a placebo version for comparison. Individuals who have used e-cigarettes for at least three months and own a smartphone may be suitable for this study. As an unphased trial, this study provides a unique opportunity to contribute to innovative research that could assist others in quitting e-cigarettes.
Do I need to stop my current medications to join the trial?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are currently on medication for e-cigarette dependence or other mental health treatments.
What prior data suggests that this attentional bias modification training is safe for young adult e-cigarette users?
Research has shown that computerized attentional bias modification training is generally safe for people. In past studies, this training was used with smokers and e-cigarette users without major safety concerns. For example, one study used a smartphone app to help smokers shift their focus away from smoking triggers and found the method well-tolerated, with no significant negative effects reported.
Another study used eye tracking with this training and found it could help reduce the urge to smoke without causing harm. While these studies mainly focus on effectiveness, the absence of safety issues suggests that the treatment is generally well-tolerated.
Overall, existing research supports attentional bias modification training as a safe option for those wanting to quit smoking or reduce e-cigarette use.12345Why are researchers excited about this trial?
Researchers are excited about computerized attentional bias modification training for quitting smoking because it offers a fresh approach compared to traditional methods like nicotine replacement therapy and behavioral counseling. This technique targets the unconscious biases that make smokers more likely to notice smoking-related cues, potentially reducing cravings and relapse. Unlike standard treatments, which often focus on managing physical addiction or changing behavior through willpower, this method aims at altering cognitive patterns associated with smoking. By addressing the mental triggers in a different way, this training could complement existing treatments and offer a new avenue for those struggling to quit.
What evidence suggests that this trial's treatments could be effective for quitting smoking?
Research has shown that computerized attentional bias modification training (ABM) has produced mixed results in helping people quit smoking. One study with 504 adult smokers found that web-based ABM training did not significantly reduce smoking or alter thinking patterns. Another study using virtual reality for similar training showed a small, short-term decrease in daily smoking. These findings suggest that while ABM has potential, its effectiveness in helping people quit smoking, particularly e-cigarette users, remains unclear. In this trial, participants will receive either the computerized attentional bias modification training or a placebo attention control training to further explore its potential with young adult e-cigarette users.16789
Who Is on the Research Team?
Seok Hyun Gwon, PhD, RN
Principal Investigator
University of Wisconsin, Milwaukee
Are You a Good Fit for This Trial?
This trial is for young adults aged 18-29 who exclusively use e-cigarettes (ENDS) and have been doing so for at least 3 months. Participants must own a smartphone but cannot be on medication or psychosocial treatment for ENDS dependence, pregnant, have serious alcohol issues, eye-tracking problems, or current psychiatric treatment for DSM-5 mental health disorders.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo attentional bias modification training or placebo attention control training
Follow-up
Participants are monitored for attentional bias, nicotine dependence, and subjective urges for e-cigarette use
What Are the Treatments Tested in This Trial?
Interventions
- Computerized attentional bias modification training
- Placebo attention control training
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Wisconsin, Milwaukee
Lead Sponsor